@article {3757,
	title = {Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community.},
	journal = {Contemporary clinical trials},
	year = {2013},
	month = {2013 Dec 30},
	abstract = {HIV-infected prisoners have a high prevalence of alcohol use disorders and commonly relapse to alcohol soon after release to the community which is linked to high morbidity, poor antiretroviral therapy (ART) adherence and increased sexual risk-taking behaviors. Extended-release naltrexone (XR-NTX) effectively reduces relapse to alcohol in alcohol dependent persons, yet it remains unexamined among criminal justice system (CJS) populations transitioning to the community.},
	issn = {1559-2030},
	doi = {10.1016/j.cct.2013.12.006},
	author = {Springer, Sandra A and Altice, Frederick L and Herme, Maua and Di Paola, Angela}
}
